BRIEF published on 04/10/2025 at 15:05, 1 year 7 months ago Eckert & Ziegler: US Consul Visits Braunschweig Radiopharmaceutical Facility Cancer Treatment Radiopharmaceuticals Lutetium-177 US Consul Visit Expansion Investment
BRIEF published on 04/10/2025 at 15:05, 1 year 7 months ago Eckert & Ziegler : Le consul américain visite l'usine radiopharmaceutique de Braunschweig Traitement Du Cancer Produits Radiopharmaceutiques Lutécium-177 Visite Du Consul Américain Investissement D'expansion
PRESS RELEASE published on 04/10/2025 at 15:00, 1 year 7 months ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
BRIEF published on 03/27/2025 at 07:50, 1 year 7 months ago Eckert & Ziegler Reports Record Year in 2024 Eckert & Ziegler 2024 Financial Results Medical Segment Isotope Products 2025 Forecast
BRIEF published on 03/27/2025 at 07:50, 1 year 7 months ago Eckert & Ziegler annonce une année record en 2024 Eckert & Ziegler Résultats Financiers 2024 Secteur Médical Produits Isotopiques Prévisions Pour 2025
PRESS RELEASE published on 03/27/2025 at 07:45, 1 year 7 months ago Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE achieved record sales of €295.8 million in 2024, with significant growth in Medical and Isotope Products segments. Forecasting sales of €320 million and EBIT of €78 million for 2025 Record Sales Eckert & Ziegler SE 2024 Financial Year Medical Segment Isotope Products Segment
BRIEF published on 03/25/2025 at 09:35, 1 year 7 months ago Eckert & Ziegler to Provide Actinium Pharmaceuticals with Actinium-225 Clinical Trials Acute Myeloid Leukemia Actinium-225 Supply Targeted Radiotherapy Global Shortage
BRIEF published on 03/25/2025 at 09:35, 1 year 7 months ago Eckert & Ziegler fournira de l'actinium-225 à Actinium Pharmaceuticals Essais Cliniques Leucémie Myéloïde Aiguë Approvisionnement En Actinium 225 Radiothérapie Ciblée Pénurie Mondiale
PRESS RELEASE published on 03/25/2025 at 09:30, 1 year 7 months ago Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities Eckert & Ziegler SE to supply Actinium Pharmaceuticals with Ac-225 for comprehensive development activities, targeting cancer treatment with radiotherapies Cancer Treatment Eckert & Ziegler SE Radiotherapy Ac-225 Actinium Pharmaceuticals
BRIEF published on 03/20/2025 at 14:05, 1 year 7 months ago Eckert & Ziegler Partner with AtomVie on Lutetium-177 Supply Radiopharmaceuticals Lutetium-177 Theralugand Global Agreement AtomVie Partnership
Published on 11/11/2026 at 03:30, 5 hours 52 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 8 hours 42 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 9 hours 52 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 10 hours 22 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 10 hours 22 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 09:05, 17 minutes ago DeepL unveils Aure, its most lifelike Voice AI translation model yet
Published on 11/11/2026 at 09:00, 22 minutes ago Municipality Finance issues a USD 50 million tap under its MTN programme
Published on 11/11/2026 at 09:00, 22 minutes ago Original-Research: Multitude AG (von NuWays AG): BUY
Published on 11/11/2026 at 09:00, 22 minutes ago Original-Research: Cantourage Group SE (von NuWays AG): BUY
Published on 11/10/2026 at 18:00, 15 hours 22 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 15 hours 37 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 15 hours 47 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 15 hours 51 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
